Drug intelligence / Profile preview

DZ-1-artesunate

Development stage
Preclinical
Lead developer
Cedars-Sinai
Modality
Peptide-Drug Conjugates → Peptide Conjugates → Peptides, Small Molecules
Administration
Intravenous
01

Overview

DZ-1-artesunate (DZ-1-ART) is an experimental small molecule drug conjugate consisting of the heptamethine cyanine dye DZ-1 and the antimalarial/anticancer agent artesunate. DZ-1 serves as a tumor-homing and mitochondria-targeting vector, utilizing the high mitochondrial membrane potential of cancer cells to achieve selective intracellular accumulation. Once localized within the mitochondria, the artesunate moiety induces the generation of reactive oxygen species (ROS), which leads to the disruption of mitochondrial membrane potential and the activation of mitochondria-mediated apoptotic pathways. The conjugate also possesses near-infrared (NIR) fluorescence properties, allowing for potential theranostic applications. Research has demonstrated its efficacy in inducing cytotoxicity in patient-derived colorectal cancer tumoroids, suggesting its potential as a precision therapy for malignant neoplasms.

Other names
heptamethine cyanine dye-conjugated artesunateDZ-1-artesunate conjugateDZ1-artesunate conjugateDZ 1-artesunate conjugate
02

Targets

OATP (Organic anion transporting polypeptides)

Beyond the preview

Go deeper on DZ-1-artesunate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DZ-1-artesunate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call